Home|Journals|Articles by Year|Audio Abstracts

Research Article

Anti Inflammatory activity of AgNps synthesized using flower formulation (Rosa andJasminum

R. Bharath, Abirami Arthanari*, S. Rajeshkumar.


Introduction: In recent years, there has been a resurgence in the use of traditional medicinal herbs, and as a result,
pharmaceutical companies are investing heavily in developing natural medications derived from plants. Nanoparticles act
in a number of potential ways and fields. Chemical synthesis of nanoparticles is no longer advantageous compared to
plant-based synthesis. The current study uses a green method to create silver nanoparticles (AgNPs) utilizing flower
Materials and methods: The anti-inflammatory activity for gel was tested by the following convention proposed by
Muzushima and Kabayashi with specific alterations. 0.05 mL of Rosa and jasminum jel of various fixations.
Result: Using rosa and jasminum extract in the manufacture of silver nanoparticles, the nanoparticles showed remarkable
antioxidant and anti-inflammatory activity. It was discovered that the cytotoxic effect was less harmful, demonstrating
biocompatibility. Rosa jasminum extract of AgNps showed good anti-inflammatory efficacy in the EA and BSA assays.
Conclusion: From our study we concluded that Silver nanoparticles were created using rosa and jasminum extract, and
the nanoparticles displayed impressive anti-inflammatory.

Key words: silver nanoparticle,rosa, jasminum,anti-inflammatory

Full-text options

Share this Article

Online Article Submission
• ejmanager.com

ejPort - eJManager.com
Review(er)s Central
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.